SCHEMBL29207685

SCHEMBL29207685

O=C1CCC(OCc2ccccc2)CON1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.41
CTSB P07858 2/20 0.41
CTSK P43235 2/20 0.41
CTSV O60911 1/20 0.41
CTSS P25774 1/20 0.41
CTSC P53634 1/20 0.41
CTSF Q9UBX1 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
PSEN1 P49768 2/20 0.40
PSEN2 P49810 2/20 0.40
APH1B Q8WW43 2/20 0.40
NCSTN Q92542 2/20 0.40
APH1A Q96BI3 2/20 0.40
PSENEN Q9NZ42 2/20 0.40
DDB1 Q16531 2/20 0.39
CRBN Q96SW2 2/20 0.39
CYP2C19 P33261 2/20 0.39
MAPT P10636 1/20 0.39
OPRM1 P35372 2/20 0.39
OPRL1 P41146 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985833 0.79 CYP3A4 (0.47) CTSLCTSBCTSKCTSVCTSS
SCHEMBL1288390 0.79 CYP3A4 (0.47) CTSLCTSBCTSKCTSVCTSS
SCHEMBL418931 0.78 SIGMAR1 (0.41) CTSLCTSBCTSKCTSVCTSS
SCHEMBL416422 0.78 OPRM1 (0.50) CTSLCTSBCTSKCTSVCTSS
SCHEMBL21004783 0.78 SIGMAR1 (0.43) CTSLCTSBCTSKCTSVCTSS
SCHEMBL20820799 0.76 SLC6A2 (0.43) CTSLCTSBCTSKSIGMAR1CYP2C19
Ethylene SCHEMBL7936439 0.75 OPRM1 (0.48) CTSLCTSBCTSKCTSVCTSS
SCHEMBL19041070 0.74 SIGMAR1 (0.42) CTSLCTSBCTSKCTSVCTSS
SCHEMBL664313 0.74 SIGMAR1 (0.45) CTSLCTSBCTSKCTSVCTSS
SCHEMBL11244939 0.73 CTSL (0.46) CTSLCTSBCTSKCTSVCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019745-A Cyclohepta-thieno-diazapine derivatives as positive allosteric modulators of the GABAA gamma 1 receptor 豪夫迈·罗氏有限公司 2024-05-10 CN disclosed